A 5p toll, two men in a booth, and centuries of loopholes dating back to 1769. We parked up, counted the cars, and tried to figure out if this thing actually makes any money. UK households urged to ...

HOUSTON, Texas (KTRK) -- Some Houston ISD students could be taking a different path to first grade next year. The district said it's launching a new Kinder Bridge program aimed at helping struggling ...

Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...

Kaicey Baylor joined WJZ as a reporter in October 2024. Before coming to Charm City, she spent the last three years as a morning reporter and multiskilled journalist at 13News Now in Norfolk, Virginia ...

Nurses in Ohio looking to advance their careers have a top-ranked option close to home. Ohio University’s online RN to BSN program has been named the best in the state and the third-best asynchronous ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. (Post updated on June 17, 2026, with new guidance from CMS.) There have been many headlines ...

A financially sustainable solution for how to cover GLP-1 drugs for obesity remains elusive. The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan.

The University of Missouri–St. Louis has announced a new partnership with the U.S. Army to create a pathway for Army Practical Nursing Specialists (also known as 68Charlies) who have trained as LPNs ...

The money set aside for the Farmer Bridge Assistance Program has almost been entirely delivered, and Chad Smith has the details on where that money went. Smith: The Farmer Bridge Assistance Program ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.